https://scholars.lib.ntu.edu.tw/handle/123456789/620279
標題: | A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer | 作者: | Reynolds K.L. Bedard P.L. Lee S.-H. Chia-Chi Lin Tabernero J. Alsina M. Cohen E. Baselga J. Blumenschein G. Graham D.M. Garrido-Laguna I. Juric D. Sharma S. Salgia R. Seroutou A. Tian X. Fernandez R. Morozov A. Sheng Q. Ramkumar T. Zubel A. Bang Y.-J. |
公開日期: | 2017 | 出版社: | BioMed Central Ltd. | 卷: | 17 | 期: | 1 | 起(迄)頁: | 646 | 來源出版物: | BMC Cancer | URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85029370515&doi=10.1186%2fs12885-017-3641-6&partnerID=40&md5=7326ca42e21909502009ab2b3452803f https://scholars.lib.ntu.edu.tw/handle/123456789/620279 |
ISSN: | 1471-2407 | DOI: | 10.1186/s12885-017-3641-6 |
顯示於: | 臨床醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。